Metabolic bone disease--recent developments
Epstein, S.
South African Medical Journal 48(9): 350-352
1974
ISSN/ISBN: 0256-9574 PMID: 4360865 Document Number: 74024
Document emailed within 1 workday
Related Documents
Kajiwara, M.; Yajima, N.; Yamato, H. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Bone histomorphometry for laboratory animals Clinical Calcium 21(4): 534-540Yoshikawa, S. 1986: Etiology and pathology of metabolic bone diseases: Paget's disease of bone and osteosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2437-2442
Mori, S. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Pathophisiology of Microdamage Clinical Calcium 21(4): 559-565
Peng, F.; Fu, R.; Liu, H.; Wang, Y.; Ding, K.; Ding, S.; Liu, Z.; Ruan, E.; Qu, W.; Wang, H.; Xing, L.; Wang, X.; Wang, G.; Song, J.; Wu, Y.; Li, L.; Liu, H.; Guan, J.; Shao, Z. 2015: Clinical significance of serum bone metabolic markers in diagnosis and monitoring of myeloma bone disease Zhonghua Yi Xue Za Zhi 95(42): 3436-3439
Villamil Cajoto, I.; Villacián Vicedo, M.J.; Martínez Rey, C. 2006: Metabolic bone disease: something more than medication Revista Clinica Espanola 206(9): 465-6; author reply 466-7
Cundy, T. 1986: Latest news on metabolic bone disease Practitioner 230(1419): 819-820
Mankin, H.J.; Mankin, C.J. 2008: Metabolic bone disease: a review and update Instructional Course Lectures 57: 575-593
Robinson, W. 1976: New metabolic bone disease research unit Nursing Mirror and Midwives Journal 143(16): 46-49
Reynolds, W.A.; Karo, J.J. 1972: Radiologic diagnosis of metabolic bone disease Orthopedic Clinics of North America 3(3): 521-543
Kanabe, S. 1986: Metabolic bone disease: calcification and matrix vesicle Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2354-2358
Armstrong, A.; Cunningham, J. 1994: The treatment of metabolic bone disease in patients on peritoneal dialysis Kidney International. Suppl 48: S51-S57
Kamboj, M.K. 2007: Metabolic bone disease in adolescents: recognition, evaluation, treatment, and prevention Adolescent Medicine: State of the Art Reviews 18(1): 24-46 Viii
Stanitski, D.F. 1994: Treatment of deformity secondary to metabolic bone disease with the Ilizarov technique Clinical Orthopaedics and Related Research 301: 38-41
Solt, D.B. 1991: The pathogenesis, oral manifestations, and implications for dentistry of metabolic bone disease Current Opinion in Dentistry 1(6): 783-791
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Caudarella, R.; Vescini, F.; Buffa, A.; Sinicropi, G.; Rizzoli, E.; La Manna, G.; Stefoni, S. 2003: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors Journal of Nephrology 16(2): 260-266
Rett, K.; Wicklmayr, M.; Dietze, G.J. 1990: Metabolic effects of kinins: historical and recent developments Journal of Cardiovascular Pharmacology 15(Suppl 6): S57-S59
Shihabi, Z.K.; Goodman, H.O.; Holmes, R.P. 1992: Recent developments in assays for taurine, hypotaurine and some metabolic precursors Advances in Experimental Medicine and Biology 315: 423-428
Nakamura, T. 2008: Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis Clinical Calcium 18(3): 374-380
Takami, M.; Shimada, H. 2010: Effects of SERMs on bone health. SERM and metabolic markers of bone Clinical Calcium 20(3): 365-371